Hosted by the Office for Translational Research and the Maxwell Centre at the University of Cambridge (UoC), this event will bring together multidisciplinary experts, from academia and industry, working on novel approaches to tackle PARPi resistance. The event is open to all researchers in the Cambridge area interested in new therapeutics.
The purpose of the CamNTF is to promote interactions between scientists from academia and industry in order to improve opportunities for biotechnology research and development.
Meeting attendance is free but all attendees must register here in advance.
Programme
17:30-18:00 Welcome, refreshments and networking
18:00 Introduction to the CamNTF: Dr Alex Samoshkin, Translational technology Manager, Office for Translational Research/Maxwell Centre, UoC.
18:05 Prof. Steve Jackson, Senior Group Leader, Cancer Research UK Cambridge Institute, UoC.
Cellular responses to DNA damage: mechanistic insights and applications in cancer therapy
18:25 Dr Josep Forment, Director, Bioscience Oncology R&D, Research & Early Development, AstraZeneca.
Understanding mechanisms of PARPi resistance and their clinical relevance
18:45 Dr Ines Prata Machado, Postdoctoral Researcher, Cancer Research UK Cambridge Institute, UoC.
Machine learning methods to predict treatment response in ovarian cancer patients
19:00 Prof. James Brenton, Senior Group Leader, Cancer Research UK Cambridge Institute, UoC.
Single cell approaches to understanding carboplatin and PARP response
19:20 Joint Q&A followed by buffet & networking
20:00 Meeting Close